Evidence map›Paper›PMID 32218136›Full record

ArticleJournal of clinical medicine2020

Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial Growth.

Andrea Gama, Laura Maman, Jorge William Vargas-Franco, Rana Omar, Bénédicte Brounais-Le Royer, Hideo Yagita, Sylvie Babajko, Ariane Berdal, Ana Carolina Acevedo, Dominique Heymann and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 5 countries.

Andrea GamaINSERM, UMR-1138, Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, Physiopathologie Orale Moléculaire, F-75006 Paris, France.
Laura MamanService d'Odontologie-Stomatologie, Hôpital Pitié-Salpêtrière, AP-HP, F-75013 Paris, France.
Jorge William Vargas-FrancoINSERM, UMR-1238, Equipe 1, Faculté de Médecine, Université de Nantes, F-44035 Nantes, France.
Rana OmarINSERM, UMR-1138, Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, Physiopathologie Orale Moléculaire, F-75006 Paris, France.
Bénédicte Brounais-Le RoyerINSERM, UMR-1238, Equipe 1, Faculté de Médecine, Université de Nantes, F-44035 Nantes, France.
Hideo YagitaDepartment of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Sylvie BabajkoINSERM, UMR-1138, Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, Physiopathologie Orale Moléculaire, F-75006 Paris, France.
Ariane BerdalINSERM, UMR-1138, Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, Physiopathologie Orale Moléculaire, F-75006 Paris, France.
Ana Carolina AcevedoOral Histopathology Laboratory, Health Sciences Faculty, University of Brasília, Brasília 70910-900, Brazil.
Dominique HeymannINSERM, LEA Sarcoma Research Unit, University of Sheffield, Department of Oncology and Human Metabolism, Medical School, Sheffield S10 2RX, UK.
Frédéric LézotINSERM, UMR-1238, Equipe 1, Faculté de Médecine, Université de Nantes, F-44035 Nantes, France.
Beatriz CastanedaService d'Odontologie-Stomatologie, Hôpital Pitié-Salpêtrière, AP-HP, F-75013 Paris, France.
Inserm · FRSorbonne Université · FRUniversidade de Brasília · BRJuntendo University · JP

Funding

INSERM Recurent fundingSFODF (Société Française d'Orthodontie Dento-Faciale) Prix 2017-2018
6 · The paper itself

Abstract

The primary retention of molars observed in clinic corresponds to a still-unexplained absence of molar eruption despite the presence of an eruption pathway, resembling the experimental transient inhibition of RANKL signaling in mice. The aim of the present study was to confront the hypothesis according to which the primary retention of molars is associated with transitory perturbations to RANKL signaling during growth as part of a wider craniofacial skeleton pattern. The experimental strategy was based on combining a clinical study and an animal study corresponding to the characterization of the craniofacial phenotypes of patients with primary retention of molars and analyses in mice of the consequences of transient inhibition of RANKL signaling on molar eruption and craniofacial growth. The clinical study validated the existence of a particular craniofacial phenotype in patients with primary retention of molars: a retromandibular skeletal class II typology with reduced mandibular dimensions which manifests itself at the dental level by a class II/2 with palatoversion of the upper incisors and anterior overbite. The animal study demonstrated that transient invalidation of RANKL signaling had an impact on the molar eruption process, the severity of which was dependent on the period of inhibition and was associated with a reduction in two craniofacial morphometric parameters: total skull length and craniofacial vault length. In conclusion, primary retention of molars may be proposed as part of the craniofacial skeleton phenotype associated with a transitory alteration in RANKL signaling during growth.

Indexed as

craniofacialgrowthprimary retention of molarsRANKL

Identifiers

PMID32218136
PMCPMC7231205
OpenAlexW3013784494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.